Follow
Ashique Rafique
Ashique Rafique
Regeneron Pharmaceutical
Verified email at regeneron.com
Title
Cited by
Cited by
Year
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
N Papadopoulos, J Martin, Q Ruan, A Rafique, MP Rosconi, E Shi, ...
Angiogenesis 15, 171-185, 2012
11852012
Kyratsous CA
J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ...
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 …, 2020
10522020
Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant
L Yurkovetskiy, X Wang, KE Pascal, C Tomkins-Tinch, TP Nyalile, Y Wang, ...
Cell 183 (3), 739-751. e8, 2020
10322020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ...
Science 369 (6506), 1010-1014, 2020
9782020
High affinity antibodies to human IL-6 receptor
S Stevens, TT Huang, JH Martin, JL Fairhurst, A Rafique, E Smith, ...
US Patent 7,582,298, 2009
4382009
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering
S Davis, N Papadopoulos, TH Aldrich, PC Maisonpierre, T Huang, ...
Nature structural biology 10 (1), 38-44, 2003
3232003
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
A Le Floc’h, J Allinne, K Nagashima, G Scott, D Birchard, S Asrat, Y Bai, ...
Allergy 75 (5), 1188-1204, 2020
2612020
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
V Gusarova, CA Alexa, Y Wang, A Rafique, JH Kim, D Buckler, IJ Mintah, ...
Journal of lipid research 56 (7), 1308-1317, 2015
2072015
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
JM Orengo, AR Radin, V Kamat, A Badithe, LH Ben, BL Bennett, S Zhong, ...
Nature communications 9 (1), 1421, 2018
2012018
Activin A more prominently regulates muscle mass in primates than does GDF8
E Latres, J Mastaitis, W Fury, L Miloscio, J Trejos, J Pangilinan, ...
Nature communications 8 (1), 15153, 2017
1632017
Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates
KE Pascal, D Dudgeon, JC Trefry, M Anantpadma, Y Sakurai, CD Murin, ...
The Journal of infectious diseases 218 (suppl_5), S612-S626, 2018
1592018
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
E Latres, J Pangilinan, L Miloscio, R Bauerlein, E Na, TB Potocky, ...
Skeletal muscle 5, 1-13, 2015
1432015
Bispecific antibodies and antibody–drug conjugates (ADCs) bridging HER2 and prolactin receptor improve efficacy of HER2 ADCs
J Andreev, N Thambi, AE Perez Bay, F Delfino, J Martin, MP Kelly, ...
Molecular cancer therapeutics 16 (4), 681-693, 2017
1382017
Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice
E Burova, A Hermann, J Waite, T Potocky, V Lai, S Hong, M Liu, ...
Molecular cancer therapeutics 16 (5), 861-870, 2017
1372017
A global benchmark study using affinity-based biosensors
RL Rich, GA Papalia, PJ Flynn, J Furneisen, J Quinn, JS Klein, ...
Analytical biochemistry 386 (2), 194-216, 2009
1242009
High affinity human antibodies to human IL-4 receptor
S Stevens, TT Huang, JH Martin, JL Fairhurst, A Rafique, M Torres, ...
US Patent 7,605,237, 2009
1222009
Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions
V Kamat, A Rafique
Analytical biochemistry 536, 16-31, 2017
1062017
Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology
MJ Cannon, GA Papalia, I Navratilova, RJ Fisher, LR Roberts, KM Worthy, ...
Analytical biochemistry 330 (1), 98-113, 2004
1012004
Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys
H Okamoto, J Kim, JP Aglione, J Lee, K Cavino, E Na, A Rafique, JH Kim, ...
Endocrinology 156 (8), 2781-2794, 2015
962015
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
D Skokos, JC Waite, L Haber, A Crawford, A Hermann, E Ullman, R Slim, ...
Science translational medicine 12 (525), eaaw7888, 2020
882020
The system can't perform the operation now. Try again later.
Articles 1–20